vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and First Bancorp, Inc (FNLC). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $25.8M, roughly 1.7× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs -19.9%, a 59.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 17.5%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 18.1%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
ABCL vs FNLC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $25.8M |
| Net Profit | $-8.9M | $10.2M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 48.1% |
| Net Margin | -19.9% | 39.4% |
| Revenue YoY | 788.4% | 17.5% |
| Net Profit YoY | 73.9% | 39.7% |
| EPS (diluted) | $-0.03 | $0.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $25.8M | ||
| Q3 25 | $9.0M | $24.5M | ||
| Q2 25 | $17.1M | $22.5M | ||
| Q1 25 | $4.2M | $21.8M | ||
| Q4 24 | $5.0M | $22.0M | ||
| Q3 24 | $6.5M | $20.5M | ||
| Q2 24 | $7.3M | $19.2M | ||
| Q1 24 | $10.0M | $18.5M |
| Q4 25 | $-8.9M | $10.2M | ||
| Q3 25 | $-57.1M | $9.1M | ||
| Q2 25 | $-34.7M | $8.1M | ||
| Q1 25 | $-45.6M | $7.1M | ||
| Q4 24 | — | $7.3M | ||
| Q3 24 | $-51.1M | $7.6M | ||
| Q2 24 | $-36.9M | $6.2M | ||
| Q1 24 | $-40.6M | $6.0M |
| Q4 25 | -63.7% | 48.1% | ||
| Q3 25 | -851.8% | 45.2% | ||
| Q2 25 | -290.2% | 43.7% | ||
| Q1 25 | -1479.6% | 39.3% | ||
| Q4 24 | — | 39.5% | ||
| Q3 24 | -1439.4% | 44.6% | ||
| Q2 24 | -1276.2% | 38.8% | ||
| Q1 24 | -551.5% | 39.3% |
| Q4 25 | -19.9% | 39.4% | ||
| Q3 25 | -637.8% | 37.0% | ||
| Q2 25 | -203.3% | 35.8% | ||
| Q1 25 | -1077.2% | 32.5% | ||
| Q4 24 | — | 33.1% | ||
| Q3 24 | -785.4% | 36.9% | ||
| Q2 24 | -504.3% | 32.1% | ||
| Q1 24 | -408.0% | 32.5% |
| Q4 25 | $-0.03 | $0.91 | ||
| Q3 25 | $-0.19 | $0.81 | ||
| Q2 25 | $-0.12 | $0.72 | ||
| Q1 25 | $-0.15 | $0.63 | ||
| Q4 24 | — | $0.66 | ||
| Q3 24 | $-0.17 | $0.68 | ||
| Q2 24 | $-0.13 | $0.55 | ||
| Q1 24 | $-0.14 | $0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | $95.5M |
| Stockholders' EquityBook value | $966.9M | $283.1M |
| Total Assets | $1.4B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | — | $95.5M | ||
| Q3 25 | — | $95.5M | ||
| Q2 25 | — | $95.0M | ||
| Q1 25 | — | $70.0M | ||
| Q4 24 | — | $95.0M | ||
| Q3 24 | — | $95.0M | ||
| Q2 24 | — | $70.0M | ||
| Q1 24 | — | $70.0M |
| Q4 25 | $966.9M | $283.1M | ||
| Q3 25 | $964.0M | $274.6M | ||
| Q2 25 | $1.0B | $265.5M | ||
| Q1 25 | $1.0B | $259.7M | ||
| Q4 24 | $1.1B | $252.5M | ||
| Q3 24 | $1.1B | $256.8M | ||
| Q2 24 | $1.1B | $244.7M | ||
| Q1 24 | $1.1B | $242.6M |
| Q4 25 | $1.4B | $3.2B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.4B | $3.2B | ||
| Q1 25 | $1.3B | $3.2B | ||
| Q4 24 | $1.4B | $3.2B | ||
| Q3 24 | $1.4B | $3.1B | ||
| Q2 24 | $1.4B | $3.1B | ||
| Q1 24 | $1.5B | $3.0B |
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.36× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.29× | ||
| Q1 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $37.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $34.6M |
| FCF MarginFCF / Revenue | -99.4% | 133.9% |
| Capex IntensityCapex / Revenue | 21.9% | 12.5% |
| Cash ConversionOCF / Net Profit | — | 3.72× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $37.8M | ||
| Q3 25 | $-52.6M | $12.9M | ||
| Q2 25 | $-32.4M | $7.4M | ||
| Q1 25 | $-11.6M | $2.2M | ||
| Q4 24 | $-108.6M | $26.0M | ||
| Q3 24 | $-28.9M | $9.8M | ||
| Q2 24 | $-30.0M | $6.4M | ||
| Q1 24 | $-41.7M | $-1.5M |
| Q4 25 | $-44.6M | $34.6M | ||
| Q3 25 | $-61.5M | $12.6M | ||
| Q2 25 | $-45.8M | $7.2M | ||
| Q1 25 | $-22.2M | $828.0K | ||
| Q4 24 | $-187.0M | $24.6M | ||
| Q3 24 | $-47.4M | $9.6M | ||
| Q2 24 | $-50.1M | $6.3M | ||
| Q1 24 | $-65.8M | $-1.8M |
| Q4 25 | -99.4% | 133.9% | ||
| Q3 25 | -687.0% | 51.4% | ||
| Q2 25 | -267.9% | 32.1% | ||
| Q1 25 | -524.0% | 3.8% | ||
| Q4 24 | -3702.8% | 111.7% | ||
| Q3 24 | -728.4% | 47.0% | ||
| Q2 24 | -683.8% | 32.9% | ||
| Q1 24 | -661.5% | -9.8% |
| Q4 25 | 21.9% | 12.5% | ||
| Q3 25 | 99.7% | 1.2% | ||
| Q2 25 | 78.2% | 0.6% | ||
| Q1 25 | 251.1% | 6.2% | ||
| Q4 24 | 1552.7% | 6.7% | ||
| Q3 24 | 284.6% | 0.5% | ||
| Q2 24 | 274.6% | 0.3% | ||
| Q1 24 | 242.5% | 1.8% |
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 1.42× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | -0.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
